Stockhead
Racura believes its reworked cancer-fighting and cardio-protective agent bisantrene will be a catalyst to push share prices forward. ... Read More The post Dr Boreham’s Crucible: A reinvented Racura on the path to commercialisation appeared first on Stockhead .
Go to News Site